Content about Regulatory and Washington

October 10, 2011

The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

October 10, 2011

The Federal Trade Commission has given Teva Pharmaceutical Industries the green light to acquire Frazer, Pa.-based drug maker Cephalon, but with some restrictions, Teva said.

October 10, 2011

More than 25 states have formed a group concerned about the potential merger of Express Scripts and Medco Health Solutions, Reuters Health reported last week.

October 7, 2011

Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

October 7, 2011

A growing number of people with Medicare are using free preventive services provided by the Affordable Care Act, the Centers for Medicare and Medicaid Services said.

October 7, 2011

The Food and Drug Administration has approved a new use for a drug made by Eli Lilly for erectile dysfunction, Lilly said Friday.

October 7, 2011

The Food and Drug Administration has approved a drug that it called the first single-pill combination treatment for Type 2 diabetes and high cholesterol.

October 7, 2011

Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.

October 6, 2011

The Food and Drug Administration has granted tentative approval to a drug made by Perrigo for dermatosis of the scalp.

October 5, 2011

The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

October 5, 2011

U.S. Department of Health and Human Services secretary Kathleen Sebelius will receive her seasonal flu vaccine and will talk about the importance of prevention measures and flu season preparedness Wednesday morning at a Walgreens "health and daily living" pilot store in Chicago.

October 5, 2011

The chairman of the House of Representatives' Committee on Education and the Workforce has introduced legislation that is designed to prevent the National Labor Relations Board from implementing sweeping changes to the workplace.

October 5, 2011

The National Association of Chain Drug Stores on Wednesday voiced its strong opposition to a piece of legislation sponsored by U.S. Rep. Jim Matheson, D-Utah, which would require a mandatory track-and-trace system — a move that could cost the typical pharmacy chain millions of dollars to implement across all stores.

October 4, 2011

Amneal last month launched its version of an epilepsy treatment.

October 4, 2011

The Food and Drug Administration has launched an initiative that is designed to assure the safety of food sold at retail.

October 4, 2011

After the Federal Trade Commission charged the maker of an alcoholic, carbonated malt beverage with deceptive advertising, the company has agreed to make changes to its product's packaging.

October 4, 2011

The National Association of Chain Drug Stores on Tuesday unveiled the print advertising component of its campaign to emphasize the anti-competitive and anti-consumer effects of the proposed merger of Express Scripts and Medco.

October 4, 2011

The National Community Pharmacists Association is recommending several ways for reducing Medicare Part D fraud, waste and abuse to the Senate Homeland Security and Government Affairs subcommittee, the group said Tuesday.

October 4, 2011

Though his term as Generic Pharmaceutical Association president and CEO began four weeks ago, Ralph Neas made his big debut Tuesday as he delivered his remarks at the GPhA-Food and Drug Administration Fall Technical Conference.

October 4, 2011

A wave of patent expirations over the next several years will open up a broad swath of drugs to generic competition, and India's Lupin Pharmaceuticals is looking to benefit, according to published reports.

October 4, 2011

Mylan must pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.

October 4, 2011

Sun Pharmaceutical Industries last month said that it has resolved issues cited in a warning letter sent to the company by the Food and Drug Administration pertaining to one of Sun Pharma's U.S.-based manufacturing facilities.

October 4, 2011

The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO's drugs by the end of the decade.

October 3, 2011

The Food and Drug Administration has approved a generic antibiotic made by Sagent Pharmaceuticals, Sagent said.

© 2014 Drug Store News. All Rights Reserved.